<h6 class="MarginalNote"><span class="wb-invisible">Marginal note:</span>1993, c. 34, s. 71(3)</h6><ul class="ProvisionList"><li><p class="Subsection amending&#xA;        "><strong><a id="s-2."><span class="sectionLabel">2.</span></a></strong> (1) The definition <span class="DefinedTerm"><dfn>“device”</dfn></span> in section 2 of the <cite class="XRefExternalAct"><a href="/eng/acts/F-27">Food and Drugs Act</a></cite> is replaced by the following:</p><section><div class="AmendedText"><dl class="Definition"><dt><p class="MarginalNoteDefinedTerm"><span class="DefinedTerm"><dfn>“device”</dfn></span></p><p class="MarginalNoteDefinedTerm"><span class="DefinedTermLink" lang="fr">« instrument »</span></p></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>“device”</dfn></span> means an instrument, apparatus, contrivance or other similar article, or an <span class="otherLang" lang="la">in vitro</span> reagent, including a component, part or accessory of any of them, that is manufactured, sold or represented for use in</p><ul class="ProvisionList"><li><p class="Paragraph">(<em>a</em>) diagnosing, treating, mitigating or preventing a disease, disorder or abnormal physical state, or any of their symptoms, in human beings or animals,</p></li><li><p class="Paragraph">(<em>b</em>) restoring, modifying or correcting the body structure of human beings or animals or the functioning of any part of the bodies of human beings or animals,</p></li><li><p class="Paragraph">(<em>c</em>) diagnosing pregnancy in human beings or animals,</p></li><li><p class="Paragraph">(<em>d</em>) caring for human beings or animals during pregnancy or at or after the birth of the offspring, including caring for the offspring, or</p></li><li><p class="Paragraph">(<em>e</em>) preventing conception in human beings or animals;</p></li></ul><p class="ContinuedDefinition">however, it does not include such an instrument, apparatus, contrivance or article, or a component, part or accessory of any of them, that does any of the actions referred to in paragraphs (<em>a</em>) to (<em>e</em>) solely by pharmacological, immunological or metabolic means or solely by chemical means in or on the body of a human being or animal;</p></dd></dl></div></section></li><li><p class="Subsection amending&#xA;        ">(2) The definition <span class="DefinedTermLink" lang="fr">étiquette</span> in section 2 of the French version of the Act is replaced by the following:</p><section><div class="AmendedText" lang="fr"><dl class="Definition"><dt><p class="MarginalNoteDefinedTerm"><span class="DefinedTermLink" lang="fr">« étiquette »</span></p><p class="MarginalNoteDefinedTerm"><span class="DefinedTerm"><dfn>“label”</dfn></span></p></dt><dd><p class="Definition"><span class="DefinedTermLink" lang="fr">étiquette</span> Sont assimilés aux étiquettes les inscriptions, mots ou marques accompagnant les aliments, drogues, cosmétiques, instruments ou emballages ou s’y rapportant.</p></dd></dl></div></section></li><li><p class="Subsection amending&#xA;        ">(3) Section 2 of the Act is amended by adding the following in alphabetical order:</p><section><div class="AmendedText"><dl class="Definition"><dt><p class="MarginalNoteDefinedTerm"><span class="DefinedTerm"><dfn>“confidential business information”</dfn></span></p><p class="MarginalNoteDefinedTerm"><span class="DefinedTermLink" lang="fr">« renseignements commerciaux confidentiels »</span></p></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>“confidential business information”</dfn></span>, in respect of a person to whose business or affairs the information relates, means  —  subject to the regulations  —  business information</p><ul class="ProvisionList"><li><p class="Paragraph">(<em>a</em>) that is not publicly available,</p></li><li><p class="Paragraph">(<em>b</em>) in respect of which the person has taken measures that are reasonable in the circumstances to ensure that it remains not publicly available, and</p></li><li><p class="Paragraph">(<em>c</em>) that has actual or potential economic value to the person or their competitors because it is not publicly available and its disclosure would result in a material financial loss to the person or a material financial gain to their competitors;</p></li></ul></dd><dt><p class="MarginalNoteDefinedTerm"><span class="DefinedTerm"><dfn>“therapeutic product”</dfn></span></p><p class="MarginalNoteDefinedTerm"><span class="DefinedTermLink" lang="fr">« produit thérapeutique »</span></p></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>“therapeutic product”</dfn></span> means a drug or device or any combination of drugs and devices, but does not include a natural health product within the meaning of the <cite class="XRefExternalRegulation"><a href="/eng/regulations/SOR-2003-196">Natural Health Products Regulations</a></cite>;</p></dd><dt><p class="MarginalNoteDefinedTerm"><span class="DefinedTerm"><dfn>“therapeutic product authorization”</dfn></span></p><p class="MarginalNoteDefinedTerm"><span class="DefinedTermLink" lang="fr">« autorisation relative à un produit thérapeutique »</span></p></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>“therapeutic product authorization”</dfn></span> means an authorization  —  including a licence and a suspended authorization or licence  —  that is issued under the regulations and that authorizes, as the case may be, the import, sale, advertisement, manufacture, preparation, preservation, packaging, labelling, storage or testing of a therapeutic product;</p></dd></dl></div></section></li></ul>
